The Manufacturers Life Insurance Company Purchases Shares of 80,893 HealthEquity, Inc. $HQY

The Manufacturers Life Insurance Company purchased a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the 2nd quarter, HoldingsChannel reports. The firm purchased 80,893 shares of the company’s stock, valued at approximately $7,306,000.

Other institutional investors have also made changes to their positions in the company. BlackRock Inc. acquired a new position in shares of HealthEquity during the 2nd quarter worth about $1,018,621,000. William Blair Investment Management LLC bought a new position in HealthEquity in the 4th quarter worth approximately $169,956,000. Wasatch Advisors LP increased its position in HealthEquity by 10.5% in the 2nd quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company’s stock worth $719,014,000 after buying an additional 757,801 shares during the period. Norges Bank acquired a new position in shares of HealthEquity during the fourth quarter worth approximately $66,927,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of HealthEquity during the second quarter worth approximately $60,177,000. 99.55% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Adrian T. Dillon sold 7,632 shares of the stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the completion of the transaction, the director directly owned 62,395 shares of the company’s stock, valued at approximately $6,527,140.95. This represents a 10.90% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 2,470 shares of the business’s stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $95.00, for a total value of $234,650.00. Following the completion of the sale, the executive vice president directly owned 56,643 shares in the company, valued at approximately $5,381,085. This represents a 4.18% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 12,456 shares of company stock valued at $1,256,664. 1.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on HQY shares. Wells Fargo & Company set a $111.00 price objective on shares of HealthEquity in a research note on Monday, June 1st. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, August 22nd. Telsey Advisory Group set a $111.00 price target on shares of HealthEquity in a research report on Friday. KeyCorp restated an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Finally, Citizens Jmp upped their price objective on shares of HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research report on Monday, June 1st. Eleven analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.93.

Key Headlines Impacting HealthEquity

Here are the key news stories impacting HealthEquity this week:

• Positive Sentiment: HealthEquity exceeded expectations with adjusted earnings of $1.24 per share versus the $1.19 consensus, while revenue reached $350.7 million, slightly above estimates. Revenue increased 95.5% year over year. HealthEquity Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Profitability improved, with net income rising 10% to $65.6 million and net margin expanding to 19% from 18%. Adjusted EBITDA grew 11% to $167 million, while its margin increased to 48% from 46%. HealthEquity Second-Quarter Financial Results
• Positive Sentiment: Management raised fiscal 2027 adjusted EPS guidance to $4.66–$4.73, above the $4.56 analyst consensus. Record HSA assets of $37.9 billion provide additional support for the company’s long-term growth outlook. HealthEquity Raises Fiscal 2027 Guidance
• Positive Sentiment: BTIG Research reaffirmed its “buy” rating and raised its price target to $115. Another analysis indicated that HQY could be approximately 19% undervalued after the guidance increase, reinforcing the bullish interpretation of the earnings update. BTIG Research Rating HealthEquity Could Be Undervalued
• Neutral Sentiment: Fiscal 2027 revenue guidance of approximately $1.4 billion was broadly in line with expectations, so the guidance improvement was driven mainly by stronger anticipated earnings and margins.
• Negative Sentiment: Director Adrian T. Dillon sold 7,632 shares valued at approximately $798,000, reducing his position by 10.9%. The sale was executed under a pre-arranged Rule 10b5-1 plan, which reduces its negative signaling value but could still attract investor attention. HealthEquity Director Stock Sale
• Negative Sentiment: HQY trades at a premium valuation of roughly 35 times earnings. After the recent advance toward its 52-week high, some investors may lock in gains, potentially tempering the stock’s reaction to otherwise favorable fundamentals.

HealthEquity Stock Performance

Shares of HQY stock opened at $96.37 on Monday. The firm has a fifty day moving average of $98.16 and a 200-day moving average of $87.93. The stock has a market cap of $7.97 billion, a price-to-earnings ratio of 34.79, a P/E/G ratio of 1.53 and a beta of 0.21. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $107.62. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.99 and a current ratio of 2.99.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The business had revenue of $350.73 million for the quarter, compared to analyst estimates of $349.22 million. HealthEquity’s revenue for the quarter was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, equities research analysts forecast that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.